Follicular lymphoma grade IIIb, intrathoracic lymph nodes
ICD-10 C82.42 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiib, intrathoracic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIb indicates a more aggressive form of the disease, where there is a predominance of large cells, often leading to a poorer prognosis compared to lower grades. The designation 'intrathoracic lymph nodes' specifies that the lymphoma is primarily affecting lymph nodes located within the thoracic cavity, which can include mediastinal and hilar nodes. Patients may present with B-symptoms such as fever, night sweats, and weight loss, which are indicative of systemic involvement. Diagnosis typically involves imaging studies, such as CT scans, and biopsy of affected lymph nodes. Treatment protocols often include chemotherapy regimens, immunotherapy, or targeted therapies, depending on the stage and overall health of the patient. The management of follicular lymphoma requires a multidisciplinary approach, including oncologists, radiologists, and pathologists, to ensure optimal patient outcomes.
Comprehensive documentation of diagnosis, staging, treatment plans, and follow-up care.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing chemotherapy.
Ensure accurate grading and staging are documented to support the diagnosis and treatment plan.
Detailed imaging reports that specify the location and size of lymph nodes.
CT scans or PET scans performed to assess lymph node involvement.
Radiology reports must correlate with clinical findings to support coding.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of chemotherapy administration.
Common treatments include chemotherapy regimens such as R-CHOP, immunotherapy with monoclonal antibodies, and targeted therapies. Treatment plans are individualized based on patient health and disease stage.
